82 related articles for article (PubMed ID: 14601301)
21. N-myc Downstream-Regulated Gene 1 and Endometriosis: A Minireview.
Lou T; Liu C; Zhang Z
Crit Rev Eukaryot Gene Expr; 2017; 27(4):341-345. PubMed ID: 29283328
[TBL] [Abstract][Full Text] [Related]
22. NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients.
Wang D; Tian X; Jiang Y
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1813-20. PubMed ID: 22722710
[TBL] [Abstract][Full Text] [Related]
23. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
Nwosu ZC; Battello N; Rothley M; Piorońska W; Sitek B; Ebert MP; Hofmann U; Sleeman J; Wölfl S; Meyer C; Megger DA; Dooley S
J Exp Clin Cancer Res; 2018 Sep; 37(1):211. PubMed ID: 30176945
[TBL] [Abstract][Full Text] [Related]
24. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
Chen L; Shen AG; Wang GL; Lu P; Li XY
Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
[TBL] [Abstract][Full Text] [Related]
25. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
26. [Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma].
Zhu Z; Zhu M; Ni C
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1332-6. PubMed ID: 12509938
[TBL] [Abstract][Full Text] [Related]
27. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.
Kwak MS; Yu SJ; Yoon JH; Lee SH; Lee SM; Lee JH; Kim YJ; Lee HS; Kim CY
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2037-45. PubMed ID: 25989942
[TBL] [Abstract][Full Text] [Related]
28. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
30. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
31. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
[TBL] [Abstract][Full Text] [Related]
32. NDRG1 promotes the multidrug resistance of neuroblastoma cells with upregulated expression of drug resistant proteins.
Zhang D; Jia J; Zhao G; Yue M; Yang H; Wang J
Biomed Pharmacother; 2015 Dec; 76():46-51. PubMed ID: 26653549
[TBL] [Abstract][Full Text] [Related]
33. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
34. The role of NDRG1 in the pathology and potential treatment of human cancers.
Bae DH; Jansson PJ; Huang ML; Kovacevic Z; Kalinowski D; Lee CS; Sahni S; Richardson DR
J Clin Pathol; 2013 Nov; 66(11):911-7. PubMed ID: 23750037
[TBL] [Abstract][Full Text] [Related]
35. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.
Tang Q; Wang Q; Zhang Q; Lin SY; Zhu Y; Yang X; Guo AY
BMC Cancer; 2017 Dec; 17(1):862. PubMed ID: 29254483
[TBL] [Abstract][Full Text] [Related]
36. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
37. Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.
Liu LX; Jiang HC; Liu ZH; Zhu AL; Zhang WH; Wu LF; Zhou J; Wang XQ; Wu M
Oncol Rep; 2003; 10(6):1771-5. PubMed ID: 14534694
[TBL] [Abstract][Full Text] [Related]
38. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
[TBL] [Abstract][Full Text] [Related]
39. Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays.
Nomura T; Morishita A; Jian G; Mimura S; Kato K; Nomura K; Tani J; Miyoshi H; Yoneyama H; Sakamoto T; Fujita K; Maeda E; Kobara H; Mori H; Iwama H; Masaki T
Oncol Rep; 2013 Nov; 30(5):2476-80. PubMed ID: 23970062
[TBL] [Abstract][Full Text] [Related]
40. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
